STOCK TITAN

ICON PLC Stock Price, News & Analysis

ICLR Nasdaq

Welcome to our dedicated page for ICON PLC news (Ticker: ICLR), a resource for investors and traders seeking the latest updates and insights on ICON PLC stock.

ICON PLC (ICLR) delivers essential clinical research services across 100+ countries, supporting pharmaceutical and biotechnology development through all trial phases. This news hub provides investors and industry professionals with timely updates on operational milestones, financial performance, and strategic initiatives shaping global drug development.

Access authoritative reporting on regulatory submissions, partnership announcements, and clinical trial advancements directly impacting ICON's market position. Our curated feed eliminates information fragmentation by centralizing earnings calls, governance updates, and technology implementations critical for evaluating contract research organizations.

Key coverage areas include phase III trial initiations, FDA/EMA regulatory interactions, acquisition strategies, and capacity expansion projects. Bookmark this page for real-time updates on ICON's patient recruitment innovations and quality control enhancements that maintain compliance with evolving global standards.

Rhea-AI Summary

ICON plc (NASDAQ: ICLR) announced that CFO Brendan Brennan will present at the H.C. Wainwright Global Investment Conference on May 24, 2022, at 7:00 AM ET. Additionally, CEO Steve Cutler is set to present at the Jefferies Healthcare Conference on June 9, 2022, at 2:00 PM ET, with live webcasts available. As of March 31, 2022, ICON employed approximately 39,300 employees across 138 locations in 53 countries, providing outsourced services in clinical research to various sectors. For updates, visit the Investor section on ICON's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.6%
Tags
conferences
-
Rhea-AI Summary

ICON plc (NASDAQ: ICLR), a leading healthcare intelligence and clinical research organization, announced that CFO Brendan Brennan will present at the BofA Securities 2022 Healthcare Conference on May 10, 2022, at 5:20 PM PT. The presentation details will be available on their Investor Relations website, under the 'Events' section. ICON, headquartered in Dublin, Ireland, employs approximately 39,300 staff across 138 locations in 53 countries, providing services to various health organizations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.95%
Tags
conferences
-
News
Rhea-AI Summary

ICON plc (NASDAQ: ICLR) reported a robust first quarter for 2022, achieving record net business wins of $2,426 million and a book to bill ratio of 1.28. Revenue increased by 121.6% year on year to $1,902 million, with adjusted EBITDA growing 124.5% to $340.6 million. The company maintained a closing backlog of $19.6 billion and reaffirmed full-year revenue guidance of $7,770 - $8,050 million. Notably, a $300 million early repayment was made on Term Loan B, reducing net debt to $4.58 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.6%
Tags
none
News
Rhea-AI Summary

ICON plc (NASDAQ:ICLR), a leader in healthcare intelligence and clinical research, will host a live webcast of its Analyst Day on March 17, 2022, at 12:30 PM ET in Blue Bell, Philadelphia. The event will feature presentations from ICON's executive team and will conclude around 3:30 PM ET, followed by a Q&A session. Updates and links to the webcast will be available in the Investor section of ICON's website.

ICON, headquartered in Dublin, employs approximately 38,330 people across 142 locations globally, offering outsourced services to various organizations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.4%
Tags
conferences
-
Rhea-AI Summary

ICON plc (NASDAQ:ICLR) reported remarkable financial results for Q4 and the full year 2021. The company achieved record net business wins of $2,378 million in Q4, elevating the full-year total to $6,958 million, with a book to bill ratio of 1.27. Q4 adjusted revenue surged 147.4% year-over-year to $1,881.1 million, and the full-year revenue rose by 95.9% to $5,480.8 million. Adjusted EBITDA reached $332.5 million for Q4 and $970.0 million for the full year. The company reaffirmed its revenue guidance for 2022, projecting growth between 41.8% and 46.9%.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.91%
Tags
none
-
Rhea-AI Summary

ICON plc (NASDAQ: ICLR), a leading clinical research organization, announced that CFO Brendan Brennan will present at the Citi Healthcare Conference on February 24, 2022, at 11:45 AM ET. This event will provide valuable insights into ICON's operations and contributions to healthcare research. For updates, including live webcast links, visit the Investor section of ICON's website under 'Events.' Headquartered in Dublin, Ireland, ICON employs approximately 37,960 staff across 159 locations in 53 countries, focusing on advancing clinical research from molecule to medicine.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
conferences
Rhea-AI Summary

ICON plc (NASDAQ: ICLR) forecasts full-year 2022 revenue between $7,770 - $8,050 million, reflecting a 43-46% increase over 2021. Adjusted EPS is projected at $11.55 - $11.95, marking a growth of 21-23%. The company reaffirmed its 2021 guidance with revenues expected between $5,430 - $5,530 million. CEO Steve Cutler highlights strong customer demand with a trailing twelve-month book-to-bill ratio of 1.3x and a backlog of $18.6 billion as of the third quarter of 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
none
-
Rhea-AI Summary

ICON plc (NASDAQ: ICLR) announced that CEO Dr. Steve Cutler will present at the 40th Annual JP Morgan Healthcare Conference on January 12, 2022, at 07:30 AM ET. This conference is a significant event in the healthcare sector where industry leaders share insights. ICON, headquartered in Dublin, Ireland, employs approximately 37,960 staff globally and focuses on advancing clinical research. The company provides outsourced services to various organizations, emphasizing innovations in drug development and patient care. For updates and live webcasts, visit the Investor section on ICON's website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.28%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
none
Rhea-AI Summary

ICON plc (NASDAQ:ICLR) has released its 2020 Environmental, Social and Governance (ESG) Report, following its acquisition of PRA Health Sciences. The report outlines ESG advancements made by both organizations and details commitments and policies for the unified company. CEO Steve Cutler emphasized the focus on enhancing ESG strategies to make a positive impact. The complete report is accessible for review on ICON's official website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.63%
Tags
none

FAQ

What is the current stock price of ICON PLC (ICLR)?

The current stock price of ICON PLC (ICLR) is $150.863 as of July 2, 2025.

What is the market cap of ICON PLC (ICLR)?

The market cap of ICON PLC (ICLR) is approximately 11.6B.
ICON PLC

Nasdaq:ICLR

ICLR Rankings

ICLR Stock Data

11.60B
78.96M
0.61%
98.56%
2.09%
Diagnostics & Research
Healthcare
Link
Ireland
Dublin